Dr. Jennifer M. Specht
Claim this profileSeattle Cancer Care Alliance / University of Washington
Expert in Breast Cancer
Studies Breast cancer
11 reported clinical trials
20 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Breast Cancer
HER2 positive
Stage IV
HER2 negative
Affiliated Hospitals
Clinical Trials Jennifer M. Specht is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
FDG-PET/CT Scan Prediction
for Breast Cancer
This trial tests an imaging procedure in patients with a specific type of breast cancer. The test uses a small amount of radioactive sugar to highlight active cancer areas, helping doctors decide if more or less treatment is needed before surgery. This imaging procedure has been used successfully for diagnosis, initial staging, restaging, early treatment response assessment, evaluation of disease spread, and predicting outcomes in breast cancer.
Recruiting1 award Phase 217 criteria
More about Jennifer M. Specht
Clinical Trial Related3 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jennifer M. Specht has experience with
- Fludeoxyglucose F-18
- Pembrolizumab
- Ladiratuzumab Vedotin
- Trastuzumab
- Niraparib
- Computed Tomography
Breakdown of trials Jennifer M. Specht has run
Breast Cancer
Breast cancer
Parotid Gland Cancer
Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Jennifer M. Specht specialize in?
Is Jennifer M. Specht currently recruiting for clinical trials?
Are there any treatments that Jennifer M. Specht has studied deeply?
What is the best way to schedule an appointment with Jennifer M. Specht?
What is the office address of Jennifer M. Specht?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.